Ultrasound device developer Longport received good news last month when the Food and Drug Administration cleared its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm. Longport
Ultrasound device developer Longport received good news last month when the Food and Drug Administration cleared its Longport Digital Scanner (LDS), a portable ultrasound scanner that captures and reproduces images of soft tissue down to 2 cm. Longport applied for 510(k) clearance for the unit in January (SCAN 1/13/99).
The clearance covers dermatological indications, but the Swarthmore, PA, firm is researching other uses for the device, such as podiatric, physical therapy, dental, and burn treatment indications. The company plans to rent the unit to clients in a range of settings, including private physician offices and outpatient centers. Rental will cost about $4000 per month, and will include service, upgrades, and access to an Internet educational database. Longport has a waiting list for LDS of more than 100 clients, the company said.
Could Virtual Non-Contrast Images from Photon-Counting CT Reduce Radiation Dosing with CCTA?
March 28th 2024Emerging research on coronary artery calcium scoring for the assessment of coronary artery disease (CAD) suggests the use of virtual non-contrast images from photon-counting CT may lead to a nearly 20 percent reduction in radiation dosing.
FDA Clears CT-Based AI Tools for PE Detection and Stroke Severity Assessment
March 26th 2024The artificial intelligence (AI) modalities CINA-iPE and CINA-ASPECTS may facilitate improved detection of incidental pulmonary embolism and stroke evaluation, respectively, based on computed tomography (CT) scans.